NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIEHS E-125-2018-2-FR-01 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS FR EP 19723298.6 Issued
NIEHS E-125-2018-2-DE-01 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS DE EP 19723298.6 Issued
NIEHS E-125-2018-2-EP-03 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS EP National Stage 19723298.6 Issued
NIEHS E-125-2018-2-CH-01 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS CH EP 19723298.6 Issued
NIEHS E-125-2018-2-GB-01 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS GB EP 19723298.6 Issued
NHLBI E-287-2015-0-US-03 DEVICES AND METHODS FOR EFFECTUATING PERCUTANEOUS GLENN AND FONTAN PROCEDURES US CON 16/399,670 11179156 Issued PDF
NCI E-040-2012-0-AU-32 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AU DIV 2019203042 Issued
NIEHS E-125-2018-2-PCT-01 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS PCT PCT COMB PCT/US2019/29801 Expired
NIEHS E-125-2018-2-CN-05 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS CN National Stage 201980029352.0 Pending
NCI E-103-2021-0-PCT-02 USE OF LENTIVECTOR TRANSDUCED T-RAPA CELLS FOR AMELIORATION OF LYSOSOMAL STORAGE DISORDERS PCT PCT PCT/US2019/029639 Expired
NCI E-103-2021-0-EP-01 USE OF LENTIVECTOR TRANSDUCED T-RAPA CELLS FOR AMELIORATION OF LYSOSOMAL STORAGE DISORDERS EP DIV 23190055.6 Pending
NCI E-765-2013-0-US-08 MULTIFUNCTIONAL RNA NANOPARTICLES AND METHODS OF USE US CON 16/397,534 Abandoned
NHLBI E-112-2019-0-US-01 A Principal Component Analysis Based Multi-baseline Phase Correction Method For PRF Thermometry US 62/840,006 Abandoned
NHGRI E-164-2020-1-US-01 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS US 62/839,761 Abandoned
NHGRI E-176-2020-0-US-01 METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY US 62/829,771 Abandoned
NCI E-188-2016-0-US-03 STABLE WATER ISOTOPE LABELING AND MAGNETIC RESONANCE IMAGING FOR VISUALIZATION OF RAPIDLY DIVIDING CELLS US National Stage 16/345,612 11684306 Issued PDF
NIDCR E-142-2011-0-US-10 AAV MEDIATED EXENDIN-4 GENE TRANSFER TO SALIVARY GLANDS TO PROTECT SUBJECTS FROM DIABETES OR OBESITY US DIV 16/396,262 11207361 Issued PDF
NIMH E-126-2018-0-PCT-02 NR2B LIGANDS; METHOD OF MAKING; AND USE THEREOF PCT PCT PCT/US2019/029285 Expired
NIMH E-126-2018-0-EP-04 NR2B LIGANDS; METHOD OF MAKING; AND USE THEREOF EP National Stage 19722432.2 Abandoned
NIMH E-345-2013-0-AU-07 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches AU DIV 2019202928 Abandoned
NHLBI E-045-2018-0-US-06 Vascular Anchoring Introducer Sheath US National Stage 16/394,182 11071535 Issued PDF
NINDS E-102-2019-0-US-01 HIGH-RESOLUTION CEREBROSPINAL FLUID-SUPPRESSED T2*-WEIGHTED MAGNETIC RESONANCE IMAGING OF CORTICAL LESIONS US 62/838,578 Abandoned
NIAID E-215-2016-1-US-03 PREFUSION PIV F IMMUNOGENS AND THEIR USE US National Stage 16/344,772 11078239 Issued PDF
NCI E-266-2011-0-HK-34 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage HK EP 19122845.1 Issued
NIAID E-234-2016-1-US-03 PREFUSION CORONAVIRUS SPIKE PROTEINS AND THEIR USE US National Stage 16/344,774 10960070 Issued PDF
NCATS E-060-2019-0-US-01 ANOCICEPTOR DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS US 62/837,891 Abandoned
NCATS E-118-2019-0-US-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF US 62/838,083 Abandoned
NIAID E-018-2018-0-TW-03 CHIMERIC VECTORS TW ORD 108114132 Issued
NIAID E-051-2002-0-US-19 METHODS FOR USING EXTRACELLULAR ADENOSINE INHIBITORS AND
ADENOSINE RECEPTOR INHIBITORS TO ENHANCE IMMUNE RESPONSE AND
INFLAMMATION 		US CON 16/391,423 11471528 Expired PDF
NCI E-750-2013-0-GB-24 Methods for Subtyping Lymphoma Types by Means of Expression Profiling GB EP 19170689.4 Issued
NCI E-750-2013-0-EP-11 Methods for Subtyping Lymphoma Types by Means of Expression Profiling EP DIV 19170689.4 Issued
NCI E-750-2013-0-DE-21 Methods for Subtyping Lymphoma Types by Means of Expression Profiling DE EP 19170689.4 Issued
NCI E-750-2013-0-FR-23 Methods for Subtyping Lymphoma Types by Means of Expression Profiling FR EP 19170689.4 Issued
NCI E-750-2013-0-ES-22 Methods for Subtyping Lymphoma Types by Means of Expression Profiling ES EP 19170689.4 Issued
NIAID E-018-2018-0-PCT-02 CHIMERIC VECTORS PCT PCT PCT/US2019/028771 Expired
NCI E-122-2018-0-PCT-02 COMPOSITIONS AND METHODS FOR MODULATINGvENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION PCT PCT PCT/US2019/028690 Expired
NCATS E-193-2018-0-PCT-02 Improved CRISPR Therapy PCT PCT PCT/US2019/028635 Expired
NIMH E-107-2019-0-US-01 PDE4D INHIBITORS US 62/837,352 Abandoned
NICHD E-003-2014-0-US-07 CARTILAGE TARGETING AGENTS AND THEIR USE US DIV 16/391,101 10954291 Issued PDF
NHGRI E-243-2012-0-US-18 SYNTHETIC METHYLMALONYL-COA MUTASE TRANSGENE FOR THE TREATMENT OF MUT CLASS METHYLMALONIC ACIDEMIA (MMA) US CON 16/390,917 10894077 Issued PDF
NIA E-205-2006-2-US-27 Preparation Of R,R-fenoterol And R,R-fenoterol Analogues And Their Use In Congestive Heart Failure US CON 16/390,982 10562843 Issued PDF
NCI E-094-2018-0-PCT-02 METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF PCT PCT PCT/US2019/028513 Expired
NCI E-056-2011-0-US-02 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS US CON 16/389,235 11944673 Issued PDF
NCI E-173-2018-2-US-02 Viral Methods Of T Cell Therapy US CON 16/389,586 Abandoned
NIBIB E-005-2012-2-US-08 ILLUMINATION MICROSCOPY SYSTEMS AND METHODS US CON 16/387,842 10656403 Issued PDF
NHLBI E-114-2019-0-US-01 A Pre-emphasis Technique Based On The Temperature-dependent Gradient System Behavior For Trajectory Correction In MR Imaging US 62/835,882 Abandoned
NIAID E-101-2018-0-US-04 Multi-Specific Antibodies Targeting Human Immunodeficiency Virus And Methods Of Using The Same US National Stage 16/342,962 11149082 Issued PDF
NIAID E-297-2016-2-AU-02 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES AU National Stage 2017332789 Issued
NHLBI E-211-2018-4-US-02 Methods Of Inhibiting Viruses Using Compositions Targeting TSG101-Ubiquitin Interaction US National Stage 16/342,695 Pending
NIAID E-297-2016-2-EP-03 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES EP National Stage 17778443.6 Pending